Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00020891 | CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00147212 | ET 743 (Yondelis) in Men With Advanced Prostate Cancer | completed | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00289341 | Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. | completed | Phase 1 / Phase 2 | 24 | Rockefeller UniversityOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00738673 | Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer | completed | Phase 2 | 37 | Ferring PharmaceuticalsINDUSTRY | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00014352 | Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00059943 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | completed | Phase 2 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00967018 | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 77 | Ferring PharmaceuticalsINDUSTRY | 7 | Jan 3, 2013 | clinicaltrials |
| NCT00773305 | Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer | completed | — | 200 | Summa Health SystemOTHER | 0 | Dec 28, 2012 | clinicaltrials |
| NCT00295750 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | Phase 3 | 620 | Ferring PharmaceuticalsINDUSTRY | 12 | Dec 19, 2012 | clinicaltrials |
| NCT00299741 | Study of SU11248 in Men With Advanced Prostate Cancer | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00923416 | Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events | completed | — | 240 | University Health Network, TorontoOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT01752140 | A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme | completed | N/A | 463 | Hospital de Santa Maria, PortugalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00623090 | Internet-Based Education for Prostate Cancer Screening(PCSEd) | completed | Phase 3 | 1,893 | Georgetown UniversityOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00564928 | A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer(IPI-504-04) | completed | Phase 2 | 19 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00684905 | Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00005048 | Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00616291 | Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer | completed | Phase 1 | 14 | Baylor College of MedicineOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT01191931 | Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)(PHS-02) | completed | — | 52 | Advanced Medical Diagnostics s.a.INDUSTRY | 5 | Oct 29, 2012 | clinicaltrials |
| NCT00084825 | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00771966 | Radical Prostatectomy and Perioperative Fluid Therapy | completed | Phase 4 | 44 | Rigshospitalet, DenmarkOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,005 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00658229 | The Physical Exercise and Prostate Cancer Study(PEPC) | completed | Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT00080678 | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases | completed | Phase 2 | 116 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 12, 2012 | clinicaltrials |
| NCT00327340 | Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC | completed | Phase 2 | 70 | Achieve Life SciencesINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | completed | N/A | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00833248 | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | Phase 3 | 246 | Ferring PharmaceuticalsINDUSTRY | 7 | Oct 4, 2012 | clinicaltrials |
| NCT00284752 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | completed | Phase 2 | 56 | Kaiser PermanenteOTHER | 1 | Oct 1, 2012 | clinicaltrials |
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | completed | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 2 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00042731 | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | completed | N/A | 79 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00065208 | Reiki/Energy Healing in Prostate Cancer | completed | Phase 1 / Phase 2 | 79 | The Cleveland ClinicOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00617617 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00739791 | Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer | completed | N/A | 34 | University of California, San FranciscoOTHER | 0 | Sep 14, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00992615 | Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer | completed | N/A | — | Poitiers University HospitalOTHER | 1 | Aug 29, 2012 | clinicaltrials |
| NCT00041301 | Assessing Quality of Life of Patients With Prostate Cancer | completed | — | 625 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Aug 27, 2012 | clinicaltrials |
| NCT00081601 | Study of CEP-701 in Treatment of Prostate Cancer | completed | Phase 2 | 30 | CephalonINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00752739 | Selenium in Treating Patients With Prostate Cancer | completed | Phase 2 | 220 | University of ArizonaOTHER | 1 | Aug 15, 2012 | clinicaltrials |
| NCT00978718 | Selenium in Preventing Prostate Cancer | completed | Phase 3 | 700 | University of ArizonaOTHER | 0 | Aug 15, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2013source: clinicaltrials